Lifitegrast
NDC 59651-450, Lifitegrast, for solution, from Aurobindo Pharma Limited.
- Product NDC
- 59651-450
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- FOR SOLUTION
- Route
- OPHTHALMIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-450 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIFITEGRAST50 mg/mL
Pharmacologic classes
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]; Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-450-60 | 59651045060 | 60 POUCH in 1 CARTON (59651-450-60) / 5 AMPULE in 1 POUCH (59651-450-05) / .2 mL in 1 AMPULE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1d4b4b61-79da-4b6f-bb19-056d111bf400
Use it
Look up 59651-450 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-450 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-450. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.